Multimodal histopathologic models stratify hormone receptor-positive early breast cancer
For patients with hormone receptor-positive, early breast cancer without HER2 amplification, multigene expression assays including Oncotype DX ® recurrence score (RS) have been clinically validated...
biorxiv.org